Suppr超能文献

肝再次移植患者的预后因素及结局

Prognostic Factors and Outcomes of Patients After Liver Retransplantation.

作者信息

Masior Ł, Grąt M, Krasnodębski M, Patkowski W, Figiel W, Bik E, Krawczyk M

机构信息

Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.

Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.

出版信息

Transplant Proc. 2016 Jun;48(5):1717-20. doi: 10.1016/j.transproceed.2016.01.055.

Abstract

BACKGROUND

Despite great progress and improvement in results of orthotopic liver transplantation (OLTx), 10%-20% of patients still require retransplantation (re-OLTx). The aim of the study was to present long-term results of liver retransplantation and to determine the factors influencing outcomes.

PATIENTS AND METHODS

From December 1994 to July 2014, a total of 1461 liver transplantations were performed in the Department of General, Transplant and Liver Surgery of Medical University of Warsaw. There were 92 retransplantations (6.3%), including 40 early re-OLTx (up to 30 days). The most common indication for re-OLTx were vascular complications (41/92, 44.6%). Influence of clinical variables on short- and long-term outcomes was analyzed.

RESULTS

Postoperative mortality was 30.4% (28/92). One-year, 3-year and 5-year survival for all patients was 59.8%, 56.5% and 54.1%, respectively. The best results were achieved in patients undergoing retransplantation due to chronic rejection and biliary complications, whose 5-year survival rates were 75.0% and 72.9% respectively. There was no difference in long-term survival after early and late retransplantations (60.9% and 49.3%, respectively; P = .158). Multivariable analysis revealed factors associated with longer survival of patients, namely, higher preoperative hemoglobin concentration (P = .001), increased blood transfusions (P = .048), and decreased fresh frozen plasma transfusions (P = .004).

CONCLUSIONS

Liver retransplantation is a method providing satisfactory outcomes in selected patients. The perioperative period has a major impact on patient outcome.

摘要

背景

尽管原位肝移植(OLTx)的结果取得了巨大进展和改善,但仍有10%-20%的患者需要再次移植(再次OLTx)。本研究的目的是呈现肝再次移植的长期结果,并确定影响预后的因素。

患者与方法

1994年12月至2014年7月,华沙医科大学普通、移植与肝脏外科共进行了1461例肝移植手术。其中有92例再次移植(6.3%),包括40例早期再次OLTx(30天内)。再次OLTx最常见的指征是血管并发症(41/92,44.6%)。分析了临床变量对短期和长期预后的影响。

结果

术后死亡率为30.4%(28/92)。所有患者的1年、3年和5年生存率分别为59.8%、56.5%和54.1%。因慢性排斥反应和胆道并发症接受再次移植的患者取得了最佳结果,其5年生存率分别为75.0%和72.9%。早期和晚期再次移植后的长期生存率无差异(分别为60.9%和49.3%;P = 0.158)。多变量分析显示与患者较长生存期相关的因素,即术前血红蛋白浓度较高(P = 0.001)、输血增加(P = 0.048)和新鲜冰冻血浆输注减少(P = 0.004)。

结论

肝再次移植是一种为特定患者提供满意预后的方法。围手术期对患者预后有重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验